Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer
1411.7000 -7.30 (-0.51%)
NSE Apr 28, 2025 15:31 PM
Volume: 258.3K
 

1411.70
-0.51%
Prabhudas Lilladhar
We met IPCA management, who charted out its vision to achieve a resolution Change in Estimates | Target | Reco with USFDA and turn around its business verticals which had faced challenges since CY15. IPCA's institutional tender business for anti-malaria...
Number of FII/FPI investors increased from 282 to 294 in Mar 2025 qtr.
More from Ipca Laboratories Ltd.
Recommended